Evidence map›Paper›PMID 28219321›Full record

ArticleBMC infectious diseases2017

Genetic Characterization of Vibrio cholerae O1 isolates from outbreaks between 2011 and 2015 in Tanzania.

Yazid Kachwamba, A A Mohammed, H Lukupulo, L Urio, M Majigo, F Mosha, M Matonya, R Kishimba, J Mghamba, J Lusekelo and 6 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Genome-wide investigation of outbreak-associatedFrontiers in microbiology · 2026
    Article
  3. Article
  4. Whole genome sequencing and transmission analysis ofmedRxiv : the preprint server for health sciences · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Characterisation ofThe Pan African medical journal · 2020
    Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Surveillance and Genomics of ToxigenicFrontiers in microbiology · 2019
    Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Yazid KachwambaMuhimbili University of Health and Allied Sciences, Dar es Salaam, United Republic of Tanzania.
A A MohammedTanzania Field Epidemiology and Laboratory Training Program, Dar es Salaam, United Republic of Tanzania.
H LukupuloMuhimbili University of Health and Allied Sciences, Dar es Salaam, United Republic of Tanzania.
L UrioTanzania Field Epidemiology and Laboratory Training Program, Dar es Salaam, United Republic of Tanzania.
M MajigoMuhimbili University of Health and Allied Sciences, Dar es Salaam, United Republic of Tanzania.
F MoshaNational Health Laboratory, Quality Assurance and Training Centre, Dar es Salaam, United Republic of Tanzania.
M MatonyaNational Health Laboratory, Quality Assurance and Training Centre, Dar es Salaam, United Republic of Tanzania.
R KishimbaTanzania Field Epidemiology and Laboratory Training Program, Dar es Salaam, United Republic of Tanzania.
J MghambaTanzania Field Epidemiology and Laboratory Training Program, Dar es Salaam, United Republic of Tanzania.
J LusekeloNational Health Laboratory, Quality Assurance and Training Centre, Dar es Salaam, United Republic of Tanzania.
S NyangaNational Health Laboratory, Quality Assurance and Training Centre, Dar es Salaam, United Republic of Tanzania.
M AlmeidaCenter for Bioinformatics and Computational Biology, University of Maryland, College Park, Maryland, USA.
S LiDepartment of Epidemiology and Public Health, University of Maryland, Baltimore, Maryland, USA.
D DommanWellcome Trust Sanger Instititue, Hinxton, England.
S Y MasseleMuhimbili University of Health and Allied Sciences, Dar es Salaam, United Republic of Tanzania.
O C StineDepartment of Epidemiology and Public Health, University of Maryland, Baltimore, Maryland, USA. ostin001@umaryland.edu.ORCID 0000-0003-3974-3752

Funding

EPIDEMIOLOGY &ECOLOGY OF VIBRIO CHOLERAE IN BANGLADESHR01AI039129 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SACK, DAVID A · 1996 to 2014
$15.2M
NIAID NIH HHS R01 AI039129
6 · The paper itself

Abstract

backgroundCholera outbreaks have occurred in Tanzania since 1974. To date, the genetic epidemiology of these outbreaks has not been assessed.

methods96 Vibrio cholerae O1 isolates from five regions were characterized, and their genetic relatedness assessed using multi-locus variable-number tandem-repeat analysis (MLVA) and whole genome sequencing (WGS).

resultsOf the 48 MLVA genotypes observed, 3 were genetically unrelated to any others, while the remaining 45 genotypes separated into three MLVA clonal complexes (CCs) - each comprised of genotypes differing by a single allelic change. In Kigoma, two separate outbreaks, 4 months apart (January and May, 2015), were each caused by genetically distinct strains by MLVA and WGS. Remarkably, one MLVA CC contained isolates from both the May outbreak and ones from the 2011/2012 outbreak in Dar-es-Salaam. However, WGS revealed the isolates from the two outbreaks to be distinct clades. The outbreak that started in August 2015 in Dar-es-Salaam and spread to Morogoro, Singida and Mara was comprised of a single MLVA CC and WGS clade. Isolates from within an outbreak were closely related differing at fewer than 5 nucleotides. All isolates were part of the 3

conclusionsWe conclude that genetically related V. cholerae cluster in outbreaks, and distinct strains circulate simultaneously.

Indexed as

Disease OutbreaksGenotypePhylogenyCholeraDNA, ViralGenotyping TechniquesHumansMinisatellite RepeatsMolecular EpidemiologyTanzaniaVibrio cholerae O1DNA, Viral

Identifiers

PMID28219321
PMCPMC5319185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.